Cobalamin C defect: a patient of late-onset type with homozygous p.R132* mutation.

Methylmalonic aciduria and homocystinuria, cobalamin C (cblC) type, is the most frequent inborn error of vitamin B12metabolism. The clinical phenotype includes systemic symptoms and neurological decompensation. Affected patients can be divided into two broad groups, as early-onset and late-onset. We present a Turkish patient who had neurological impairment at the age of four years as presented with late-onset cblC defect. Homozygous c.394C<T; p.R132* mutation in the MMACHC gene was detected. The patient was treated with hydroxocobalamin, betaine and folic acid combination with good clinical and biochemical response.

[1]  D. Martinelli,et al.  Cobalamin C defect: natural history, pathophysiology, and treatment , 2011, Journal of Inherited Metabolic Disease.

[2]  Xuefan Gu,et al.  Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China , 2010, Journal of Inherited Metabolic Disease.

[3]  K. Hsiao,et al.  Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria , 2010, Journal of Human Genetics.

[4]  G. Diaz,et al.  Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. , 2010, Molecular genetics and metabolism.

[5]  E. Richard,et al.  Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC) , 2009, Human mutation.

[6]  M. Baumgartner,et al.  Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype–phenotype correlations , 2009, Human mutation.

[7]  X. Gu,et al.  [Analysis of gene mutations in Chinese patients with methylmalonic acidemia and homocysteinemia]. , 2009, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[8]  C. Morel,et al.  Ocular phenotype in patients with methylmalonic aciduria and homocystinuria, cobalamin C type. , 2008, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[9]  R. Banerjee,et al.  Decyanation of vitamin B12 by a trafficking chaperone , 2008, Proceedings of the National Academy of Sciences.

[10]  G. Uziel,et al.  Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type. , 2008, Molecular genetics and metabolism.

[11]  C. Morel,et al.  Late‐onset combined homocystinuria and methylmalonic aciduria (cblC) and neuropsychiatric disturbance , 2007, American journal of medical genetics. Part A.

[12]  D. Grabli,et al.  The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[13]  S. Blaser,et al.  Late‐onset cobalamin‐C disorder: A challenging diagnosis , 2007, American journal of medical genetics. Part A.

[14]  C. Morel,et al.  Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. , 2006, Molecular genetics and metabolism.

[15]  C. Dionisi-Vici,et al.  MRI and 1H‐MRS Findings in Early-Onset Cobalamin C/D Defect , 2005, Neuropediatrics.

[16]  J. Kramer,et al.  Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment , 2005, Neurology.

[17]  R. Favier,et al.  Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  F. Bolgert,et al.  Neuropsychiatric disturbances in presumed late-onset cobalamin C disease. , 2003, Archives of neurology.

[19]  P. Kaplan,et al.  Cobalamin C deficiency complicated by an atypical glomerulopathy , 2002, Pediatric Nephrology.

[20]  A. Beaudet,et al.  Adult-onset combined methylmalonic aciduria and homocystinuria (cblC) , 2001, Neurology.

[21]  R. Biancheri,et al.  Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings. , 2001, AJNR. American journal of neuroradiology.

[22]  J. T. Black,et al.  Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency , 2001, Annals of neurology.

[23]  A. Sewell,et al.  Reversible dementia in an adolescent with cblC disease: Clinical heterogeneity within the same family , 1999, Journal of Inherited Metabolic Disease.

[24]  B. Fowler.  Genetic defects of folate and cobalamin metabolism , 1998, European Journal of Pediatrics.

[25]  M. Seashore,et al.  Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC) , 1997, Journal of Inherited Metabolic Disease.

[26]  E. R. Baumgartner,et al.  Hereditary defect of cobalamin metabolism (homocystinuria and methylmalonic aciduria) of juvenile onset. , 1996, Journal of Neurology Neurosurgery & Psychiatry.

[27]  G. Geoffroy,et al.  Clinical heterogeneity in cobalamin C variant of combined homocystinuria and methylmalonic aciduria. , 1986, The Journal of pediatrics.

[28]  H. Singer,et al.  Cobalamin C mutation (methylmalonic aciduria and homocystinuria) in adolescence. A treatable cause of dementia and myelopathy. , 1984, The New England journal of medicine.

[29]  S. Goodman,et al.  Homocystinuria with methylmalonic aciduria: two cases in a sibship. , 1970, Biochemical medicine.

[30]  R. Hammad,et al.  Seven Year Old Boy with Abnormal Behavior - Methylmalonic Aciduria and Homocystinuria , 2012 .

[31]  C. Lam,et al.  DNA-based diagnosis of methylmalonic aciduria and homocystinuria, cblC type in a Chinese patient presenting with mild developmental delay. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[32]  E. Shoubridge,et al.  Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type , 2006, Nature Genetics.